E. Coli Ribosome PTC Mutations for Sequence-Defined Polymers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for engineering ribosomes are limited in their ability to produce sequence-defined polymers and do not effectively utilize the mutational flexibility of the peptidyl transferase center, leading to inefficiencies in polymer synthesis and antibiotic resistance analysis.
Innovation Solution
Development of engineered E. coli ribosomes with mutations in the peptidyl transferase center, identified through comprehensive mutational characterization and mapping, allowing for the synthesis of diverse sequence-defined polymers and enhanced antibiotic resistance analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If comprehensive mutational characterization is performed to identify permissible ribosome mutants, then the ability to produce sequence-defined polymers is improved, but the time and resources required for mutant identification increase
Solution Approach 1:
The patent performs comprehensive mutational characterization and mapping of the ribosomal peptidyl transferase center in advance to identify all permissible mutants before they are needed for polymer synthesis. This preliminary action creates a library of characterized mutants that can be directly applied to produce diverse sequence-defined polymers without repeating the mutational screening process, thereby resolving the contradiction between versatility and time investment.
2Adaptability or versatility
If the peptidyl transferase center is mutated to enable polymer synthesis, then polymer diversity is improved, but ribosome functional activity may be reduced
Solution Approach 1:
The patent applies local quality by introducing mutations specifically in the peptidyl transferase center region of the ribosomal RNA while maintaining the rest of the ribosome structure intact. This localized modification approach allows the ribosome to gain new polymer synthesis capabilities in the PTC region while preserving its overall functional activity and reliability for translation and polymerization processes.
Solution Approach 2:
The patent systematically varies the parameters of the peptidyl transferase center by introducing different mutations (e.g., G2057U, A2058G, C2496G) and characterizing their effects on ribosome function. This parameter change approach allows identification of mutants that maintain adequate functional activity while enabling diverse polymer synthesis, thus resolving the contradiction between versatility and reliability.
3Ease of manufacture
If existing ribosome engineering methods are used, then the process is simple, but the efficiency of polymer synthesis and antibiotic resistance analysis is limited
Solution Approach 1:
The patent creates ribosome mutants that serve multiple functions: they can synthesize diverse sequence-defined polymers including polyolefins, aramids, and polyketides, and they enable improved antibiotic resistance analysis. This multi-functionality allows a single engineered ribosome system to address multiple research and production needs, thereby improving productivity without significantly increasing manufacturing complexity.
Data Source
AI summary
Disclosed are engineered or modified E. coli ribosomes and methods, components, compositions, and kits for preparing and identifying engineered or modified E. coli ribosomes. The engineered or modified E. coli ribosomes may be prepared and identified under a set of defined conditions, such as in the presences of a engineered or modified tRNA comprising a non-natural, non-α-amino acid monomer (NNA), in order to obtain an engineered or modified ribosome that utilizes the engineered or modified tRNA as a substrate for synthesizing a polymer comprising the NNA.